Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes (Q44272184)

1 December 2017

title

Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes (English)

1 reference

1 December 2017

1 reference

1 reference

Hironobu Hiyoshi

1

1 reference

1 December 2017

Mamoru Yanagimachi

2

1 reference

1 December 2017

Masashi Ito

3

1 reference

1 December 2017

Nobuyuki Yasuda

4

1 reference

1 December 2017

Toshimi Okada

5

1 reference

1 December 2017

Hironori Ikuta

6

1 reference

1 December 2017

Daisuke Shinmyo

7

1 reference

1 December 2017

Keigo Tanaka

8

1 reference

1 December 2017

Nobuyuki Kurusu

9

1 reference

1 December 2017

Ichiro Yoshida

10

1 reference

1 December 2017

Shinya Abe

11

1 reference

1 December 2017

Takao Saeki

12

1 reference

1 December 2017

Hiroshi Tanaka

13

1 reference

1 December 2017

publication date

1 January 2003

1 reference

Journal of Lipid Research

1 December 2017

published in

1 reference

1 December 2017

volume

44

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

128-135

1 reference

Regulation of the mevalonate pathway

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

(1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent squalene synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Hypertriglyceridemia as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Growth inhibition of leukemia cell line CEM-C1 by farnesol: effects of phosphatidylcholine and diacylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Preferential induction of apoptosis of leukaemic cells by farnesol

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Farnesyl analogues inhibit vasoconstriction in animal and human arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Farnesol Inhibits L-type Ca2+Channels in Vascular Smooth Muscle Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Farnesol blocks the L-type Ca2+ channel by targeting the alpha 1C subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Farnesol as a regulator of HMG-CoA reductase degradation: characterization and role of farnesyl pyrophosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Identification of a nuclear receptor that is activated by farnesol metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

S-carbocysteine-lysine salt monohydrate and cAMP cause non-additive activation of the cystic fibrosis transmembrane regulator channel in human respiratory epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Effects of NB-598, a potent squalene epoxidase inhibitor, on the apical membrane uptake of cholesterol and basolateral membrane secretion of lipids in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Fatty acid import into mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Bimodal activation of acetyl-CoA carboxylase by glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Ubiquitin-mediated regulation of 3-hydroxy-3-methylglutaryl-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

A highly conserved signal controls degradation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

Degradation of 3-hydroxy-3-methylglutaryl-CoA reductase in endoplasmic reticulum membranes is accelerated as a result of increased susceptibility to proteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200316-JLR200

10.1194/JLR.M200316-JLR200

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference